| |
AERD |
ATA |
NC |
| Number of subjects |
105 |
270 |
90 |
| Age (years) |
51.9 ± 13.7 |
50.2 ± 13.6 |
46.9 ± 19.8 |
| Gender (male) |
27 (25.7%) |
89 (33.0%) |
32 (35.6%) |
| FEV1 (% predicted) |
73.7 ± 11.3 |
75.5 ± 24.5 |
NA |
| Serum IgE(IU/mL)b |
263.5 ± 526.0 |
329.8 ± 396.7 |
NA |
| Eosinophil (cells/μL)c |
677.0 ± 787.1 |
292.4 ± 304.3 |
NA |
aData are presented as means ± SD or numbers (%).
bP<0.001 for AERD patients versus ATA patients by the Welch’s t-test.
cP<0.001 for AERD patients versus ATA patients by the Welch’s t-test. |
